Anti-factor Xa monitoring of anticoagulation during cardiopulmonary bypass in a patient with antiphospholipid syndrome

Anaesthesia and Intensive Care

Volumn 31, Issue 1, 2003, Pages 95-98

  Lennon, M J ^a   Thackray, N M ^a   Gibbs, N M ^a  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

Anti factor Xa; Antiphospholipid syndrome: anticoagulation; Cardiopulmonary bypass

Indexed keywords

BLOOD CLOTTING FACTOR 10A INHIBITOR; CARDIOLIPIN ANTIBODY; ENOXAPARIN; FENTANYL; HEPARIN; INFUSION FLUID; ISOFLURANE; MIDAZOLAM; OXYGEN; PROPOFOL; PROTAMINE; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLEEDING; BLOOD CLOTTING TIME; CARDIOPULMONARY BYPASS; CASE REPORT; FEMALE; HUMAN; PATIENT MONITORING; THROMBOSIS;

EID: 0037330707     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x0303100119     Document Type: Article

References (14)

1. Harris EN, Chan JKH, Asherton RA et al. Thrombosis, recurrent fetal loss, and thrombocytopoenia. Arch Intern Med 1986; 146:2153-2156.
2. Ciocca RG, Choi J, Graham AM. Antiphospholipid antibodies lead to increased risk in cardiovascular surgery. Am J Surg 1995; 170:198-200.
3. Santoro SA. Antiphospholipid antibodies and thrombotic predisposition: underlying pathogenic mechanism. Blood 1994; 83:2389-2391.
4. Metzdorff M, Hanses KS, Wright GL, Fried SJ. Interference with anticoagulation monitoring by procainamide induced lupus anticoagulant. Ann Thorac Surg 1996; 61:994-995.
5. Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosis (SLE) and in non-SLE disorders. Ann Int Med 1990; 12:682-698.
6. Moore RA. Monitoring hemostasis. In Lake Cl, Ed. Clinical Monitoring for Anesthesia and Critical Care, 2nd Ed. WB Saunders, Philadelphia 1994; 490-517.
7. Sheikh F, Lechowicz A, Setlur R, Rauch A, Dunn H. Recognition and management of patients with antiphospholipid antibody syndrome undergoing cardiac surgery. J Cardiothor Vasc Anesth 1997; 11:764-766.
8. Ducart AR, Collard EL, Osselaer JC et al. Management of anticoagulation during cardiopulmonary bypass in a patient with a circulating lupus anticoagulant. J Cardiothor Vasc Anesth 1997; 11:878-879.
9. Kelly JP, Leonard T, Moulder PV, Webb WR. Coronary bypass surgery in patients with circulating lupus anticoagulant. Ann Thorac Surg 1985; 40:261-263.
10. Myers G, Hirsch GM. Double valve replacement in a patient with anticardiolipin antibody syndrome. Perfusion 1999; 14:397-401.
11. Hogan WJ, McBane RD, Santrach PJ et al. Antiphospholipid syndrome and perioperative hemostatic management of cardiac valvular surgery. Mayo Clin Proc 2000; 75:971-976.
12. East CJ, Clements F, Mathew J, Slaughter TF. Antiphospholipid syndrome and cardiac surgery: management of anticoagulation in two patients. Anesth Analg 2000; 90:1098-1101.
13. Olson JD, Arkin CF, Brandt JT et al. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of unfractionated heparin therapy. Arch Pathol Lab Med 1998; 122:782-798.
14. Galli M, Finazzi G, Bevers EM, Barbui T. Kaolin clotting time and dilute Russell's viper venom time distinguish between prothrombin-dependent and beta 2-glycoprotein I-dependent antiphospholipid antibodies. Blood 1995; 86:617-623.